Cerus (CERS) Net Margin Growth (1y) (2011 - 2026)
Cerus (CERS) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -860.00 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 469.00 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 94.00 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 92.00 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -777.00 |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 350.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 85.00 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -81.00 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 67.00 |
| 10 | Cerus | 562.58 Mn | 506.32 Mn | 29.53 Mn | 571.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 571.00 |
| Mar 31, 2026 | 1,478.00 |
| Dec 31, 2025 | 128.00 |
| Sep 30, 2025 | 42,129.00 |
| Jun 30, 2025 | -102,560.00 |
| Mar 31, 2025 | 741.00 |
| Dec 31, 2024 | -217.00 |
| Sep 30, 2024 | 374,188.00 |
| Jun 30, 2024 | 1,512.00 |
| Mar 31, 2024 | 8,624.00 |
| Dec 31, 2023 | 695.00 |
| Sep 30, 2023 | -403,760.00 |
| Jun 30, 2023 | -1,384.00 |
| Mar 31, 2023 | -2,851.00 |
| Dec 31, 2022 | -992.00 |
| Sep 30, 2022 | 8,250.00 |
| Jun 30, 2022 | 8,440.00 |
| Mar 31, 2022 | 9,765.00 |
| Dec 31, 2021 | 572.00 |
| Sep 30, 2021 | 209,070.00 |